Cite
Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6 + CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma.
MLA
Li, Xiaogang, et al. “Integrated Single Cell and Bulk Sequencing Analysis Identifies Tumor Reactive CXCR6 + CD8 T Cells as a Predictor of Immune Infiltration and Immunotherapy Outcomes in Hepatocellular Carcinoma.” Frontiers in Oncology, vol. 13, Aug. 2023, p. 1099385. EBSCOhost, https://doi.org/10.3389/fonc.2023.1099385.
APA
Li, X., Gao, Z., Chen, J., Feng, S., Luo, X., Shi, Y., Tang, Z., Liu, W., Zhang, X., Huang, A., Gao, Q., Ke, A., Zhou, J., Fan, J., Fu, X., & Ding, Z. (2023). Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6 + CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma. Frontiers in Oncology, 13, 1099385. https://doi.org/10.3389/fonc.2023.1099385
Chicago
Li, Xiaogang, Zheng Gao, Jiafeng Chen, Shanru Feng, Xuanming Luo, Yinghong Shi, Zheng Tang, et al. 2023. “Integrated Single Cell and Bulk Sequencing Analysis Identifies Tumor Reactive CXCR6 + CD8 T Cells as a Predictor of Immune Infiltration and Immunotherapy Outcomes in Hepatocellular Carcinoma.” Frontiers in Oncology 13 (August): 1099385. doi:10.3389/fonc.2023.1099385.